Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
View Patent ↗Disclosed are nitric oxide delivery agents and methods of their use, more specifically to photoactive compounds, which are able to perform targeted delivery of nitric oxide in vitro and in vivo and are useful for medicinal applications including, but not limited, to blood pressure regulation and cancer treatment.
1. A composition comprising a non-porphyrin metal nitrosyl that releases nitric oxide (NO) upon illumination with light of low radiant power, wherein said non-porphyrin metal nitrosyl has a formula selected from the group consisting of
and
wherein
E is N, O or S,
Na is carboxamido-N;
M is a group 7 or group 8 transition metal in a +2, +3 or +4 oxidation state, and is not Fe II .
2. The composition of claim 1 , wherein said transition metal is selected from the group consisting of Mn II , and Ru III .
3. The composition of claim 2 , wherein said non-porphyrin metal nitrosyl is an [LM(NO) x ] n+ type, L is said pentadentate ligand, M is said transition metal, x is one or two for number of NO ligands, and n is net charge.
4. The composition of claim 2 , wherein said ligand comprises one or more pyridine rings.
5. The composition of claim 4 , wherein said ligand is PaPy 3 H.
6. The composition of claim 1 , wherein said non-porphyrin metal nitrosyl is [(PaPy 3 )Mn(NO)]ClO 4 .
7. The composition of claim 2 , wherein said light comprises ultraviolet light and said low radiant power is in the range of 1 to 50 mWatts.
8. The composition of claim 2 , wherein said light comprises visible light and said low radiant power is in the range of 25 to 250 Watts.
9. The composition of claim 4 , wherein said ligand is selected from the group consisting of PaPy 2 OH 2 , PaPy 2 SH 2 , PcPy 2 OH 2 , PcPy 2 SH 2 , PcPy 3 H, Me PcPy 3 H, Py 2 PSH, and Me PyPSH 4 .
10. The composition of claim 1 , wherein said non-porphyrin metal nitrosyl is [(PaPy 3 )Ru(NO)](BF 4 ) 2 .
11. A composition comprising a non-porphyrin metal nitrosyl that releases nitric oxide (NO) upon illumination with light of low radiant power, wherein said non-porphyrin metal nitrosyl has a formula selected from the group consisting of
and
wherein
E is O or S,
Na is carboxamido-N;
M is a group 7 or group 8 transition metal in a +2, +3 or +4 oxidation state, and is not Fe II .
12. The composition of claim 11 , wherein said transition metal is selected from the group consisting of Mn II , and Ru III .
13. The composition of claim 12 , wherein said non porphyrin metal nitrosyl is an [L′M(NO) x ] n− type, L′ is said tetradentate ligand, M is said transition metal, x is one or two for number of NO ligands, and n is net charge.
14. The composition of claim 12 , wherein said ligand comprises one or more pyridine rings.
15. The composition of claim 4 , wherein said ligand is selected from the group consisting of PaBOH 4 , PaBSH 4 , PcBOH 4 , PcBSH 4 , H 2 bpb, and H 2 Me 2 bqb.
16. The composition of claim 1 , wherein said non-porphyrin metal nitrosyl is selected from the group consisting of [(bpb)Ru(NO)(Cl)], [(Me 2 bqb)Ru(NO)(Cl)], [(Me 2 bqb)Ru(NO)(py)], and [(Me 2 bqb)Ru(NO)(Cl)].
17. The composition of claim 12 , wherein said light comprises ultraviolet light and said low radiant power is in the range of 1 to 50 mWatts.
18. The composition of claim 12 , wherein said light comprises visible light and said low radiant power is in the range of 25 to 250 Watts.
19. A method of synthesizing a metal nitrosyl, comprising:
a) deprotonating a ligand in a solvent to produce a deprotonated ligand, wherein said ligand is a pentadentate or tetradentate ligand having one or more carboxamido groups;
b) reacting a metal salt with said deprotonated ligand to produce a solution comprising an intermediate, wherein said metal is group 7 or group 8 transition metal in a +2, +3 or +4 oxidation state; and
c) passing NO through said solution to produce the composition of claim 1 comprising said nonporphyrin metal nitrosyl.
20. The method of claim 19 , wherein said transition metal is selected from the group consisting of Mn II , and Ru III .
21. The method of claim 19 , wherein said ligand is selected from the group consisting of PaPy 3 H, PaPy 2 OH 2 , PaPy 2 SH 2 , PcPy 2 OH 2 , PcPy 2 SH 2 , PcPy 3 H, Me PcPy 3 H, PaBOH 4 , PaBSH 4 , PcBOH 4 , PcBSH 4 , Py 2 PSH, Me PyPSH 4 , H 2 bpb, and H 2 Me 2 bqb.
22. A method of producing a nitrosylated compound, comprising:
a) providing the composition of claim 1 comprising said non-porphyrin metal nitrosyl;
b) contacting a compound having a free thiol group with said composition under conditions suitable for causing S-nitrosylation of said free thiol to produce a nitrosylated compound.
23. The method of claim 22 , wherein said conditions comprise maintaining temperature in a range of 4° C. to 42° C.
24. The method of claim 22 , wherein said non-porphyrin metal nitrosyl is [(PaPy 3 )Ru(NO)](BF 4 ) 2 , and said conditions comprise illumination with light of low radiant power, wherein said light comprises ultraviolet light and said low radiant power is in the range of 1 to 50 mWatts.
25. The method of claim 22 , wherein said non-porphyrin metal nitrosyl is selected from the group consisting of [(PaPy 3 )Fe(NO)](ClO 4 ) 2 , [(PcPy 3 )Fe(NO)](ClO 4 ) 2 , and [(MePcPy 3 )Fe(NO)](ClO 4 ) 2 , and said conditions comprise an absence of light.
26. The method of claim 22 , wherein said compound having a free thiol group is a cysteine protease.